Literature DB >> 10771002

Nicotinic acetylcholine receptor gene expression in developing chick autonomic ganglia.

L Erkman1, J Matter, L Matter-Sadzinski, M Ballivet.   

Abstract

The developmental expression patterns of ten genes encoding nicotinic acetylcholine receptor subunits were analyzed using Northern blots and in situ hybridization in chick peripheral ganglia of neural crest, placodal and dual embryonic origin. The superior cervical and ciliary ganglia were investigated in detail because they accumulated relatively abundant transcripts of the alpha3, beta4, alpha5 and alpha7 genes. In the superior cervical ganglion, these four mRNA species had similar developmental time-courses. They appeared at embryonic day 8 (E8), increased steadily until E16 and maintained a rather high plateau level until E18. In the ciliary ganglion, alpha7 transcripts were already abundant at E6, increased until E10, and considerably decreased thereafter. High-resolution in situ hybridization showed that alpha7 transcripts were present in all cell types of the E6 ciliary ganglion, whereas they were restricted to large neuronal somas at E16. Transfections with a reporter gene under the control of the alpha7 promoter demonstrated that a sharp developmental divide occurred at E11-12, after which stage the promoter was activatable in neurons exclusively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771002     DOI: 10.1016/s0014-2999(00)00029-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit.

Authors:  Ningshan Wang; Avi Orr-Urtreger; Joab Chapman; Ruth Rabinowitz; Rachel Nachman; Amos D Korczyn
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

2.  Distribution of α7 Nicotinic Acetylcholine Receptor Subunit mRNA in the Developing Mouse.

Authors:  Ron S Broide; Ursula H Winzer-Serhan; Yling Chen; Frances M Leslie
Journal:  Front Neuroanat       Date:  2019-08-06       Impact factor: 3.856

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.